Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.
byBenzinga Newsdesk
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Analysis: What Movies Audiences Wanted (And Rejected) During The First Half Of 2022

By Phil Hall
July 3, 8:35 AM
The first half of 2022’s movie year was marked with several intriguing surprises that could reshape film production and exhibition trends for years to come. And The Winners Are: For the films that were in U.S. theatrical release from New Year’s Day through June 30, here are the top 10 grossing films, as per data published by Box Office Mojo:

CMCSA